BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 9494592)

  • 1. Platinum compounds and paclitaxel in advanced epithelial ovarian cancer.
    Gadducci A; Brunetti I; Cosio S; Giannessi PG; Genazzani AR; Conte P
    Anticancer Res; 1997; 17(6D):4703-8. PubMed ID: 9494592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of advanced ovarian cancer.
    Martoni A; Cacciari N; Angelelli B; Zamagni C; Pannuti F
    Front Biosci; 1997 Mar; 2():g20-6. PubMed ID: 9159262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for advanced ovarian cancer: overview of randomized trials.
    Thigpen JT
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):11-6. PubMed ID: 10952121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent advances in ovarian cancer chemotherapy from the survival standpoint].
    Hatae M; Onishi Y; Maeda Y; Maeda T; Hirano T; Kamitomo M
    Gan To Kagaku Ryoho; 1995 May; 22(6):718-25. PubMed ID: 7755379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gynecologic oncology group trials in ovarian carcinoma.
    Ozols RF
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-10-S2-12. PubMed ID: 9045325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Options for primary chemotherapy in advanced ovarian cancer: the European perspective.
    Colombo N; Maggioni A; Vignali M; Parma G; Mangioni C
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S108-13. PubMed ID: 7835793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer.
    Ozols RF
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):3-7. PubMed ID: 10952119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [First line chemotherapy for advanced ovarian cancer in 2000: standards and questions].
    Cure H; Dauplat J; Cholet P
    Bull Cancer; 2000 Feb; 87(2):189-99. PubMed ID: 10705290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Latest information in the diagnoses of ovarian carcinoma].
    Isonishi S
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1351-7. PubMed ID: 12214460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carboplatin in cancer of the ovary].
    Pujade-Lauraine E; Guastalla JP; Vincent P
    Bull Cancer; 2000 Aug; 87 Spec No():40-7. PubMed ID: 11082722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities].
    du Bois A; Lück HJ; Meerpohl HG
    Zentralbl Gynakol; 1997; 119(7):299-323. PubMed ID: 9340970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of advanced ovarian cancer.
    McGuire WP; Ozols RF
    Semin Oncol; 1998 Jun; 25(3):340-8. PubMed ID: 9633846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and future directions of platinum/paclitaxel-based chemotherapy of ovarian cancer.
    Markman M
    Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-24-S11-27. PubMed ID: 9314295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of advanced ovarian cancer: current status and future directions.
    Ozols RF; Vermorken JB
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-1-S2-9. PubMed ID: 9045324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
    Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY
    Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel/carboplatin for the initial treatment of advanced ovarian cancer.
    Neijt JP; du Bois A
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):78-83. PubMed ID: 10190786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The results of a quantitative overview of chemotherapy in advanced ovarian cancer: what can we learn?
    Stewart LA; Parmar MK
    Bull Cancer; 1993 Feb; 80(2):146-51. PubMed ID: 8173166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.